| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.367 | 12.290 | 12.049 | 9.352 | 7.401 | 3.608 | 3.487 | 10.236 | 6.823 | 11.149 |
| Total Income - EUR | 9.367 | 12.290 | 12.049 | 9.352 | 7.401 | 5.219 | 3.487 | 10.236 | 6.823 | 11.149 |
| Total Expenses - EUR | 6.806 | 11.086 | 9.631 | 11.945 | 11.378 | 7.695 | 9.389 | 10.732 | 11.339 | 14.922 |
| Gross Profit/Loss - EUR | 2.561 | 1.203 | 2.418 | -2.593 | -3.977 | -2.476 | -5.902 | -496 | -4.516 | -3.773 |
| Net Profit/Loss - EUR | 2.280 | 958 | 2.297 | -2.687 | -4.051 | -2.512 | -5.937 | -599 | -4.584 | -4.107 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pro Medica 2001 Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.067 | 8.287 | 6.360 | 6.243 | 3.583 | 3.515 | 3.437 | 3.447 | 3.437 | 0 |
| Current Assets | 18.831 | 21.820 | 25.181 | 21.972 | 18.379 | 15.724 | 12.961 | 9.145 | 4.809 | 5.113 |
| Inventories | 0 | 0 | 934 | 193 | 336 | 371 | 588 | 885 | 797 | 1.137 |
| Receivables | 18.652 | 21.687 | 23.809 | 21.719 | 17.989 | 15.349 | 12.216 | 8.196 | 2.949 | 2.933 |
| Cash | 179 | 133 | 438 | 60 | 55 | 4 | 157 | 64 | 1.063 | 1.044 |
| Shareholders Funds | 28.444 | 29.111 | 30.010 | 26.773 | 22.204 | 19.271 | 12.906 | 12.348 | 7.726 | 158 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 454 | 996 | 1.531 | 1.443 | -242 | -32 | 3.491 | 245 | 520 | 4.956 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8513 - 8513" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Pro Medica 2001 Srl